DekaBank Deutsche Girozentrale’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130M Hold
1,858,556
0.22% 106
2026
Q1
$133M Hold
1,858,556
0.22% 107
2025
Q4
$137M Hold
1,858,556
0.24% 96
2025
Q3
$140M Hold
1,858,556
0.24% 99
2025
Q2
$127M Sell
1,858,556
-43,352
-2% -$2.84M 0.23% 108
2025
Q1
$127M Buy
1,901,908
+43,352
+2% +$2.59M 0.25% 103
2024
Q4
$82M Hold
1,858,556
0.15% 153
2024
Q3
$114M Buy
1,858,556
+1,282,956
+223% +$74.8M 0.21% 117
2024
Q2
$33.8M Sell
575,600
-1,326,308
-70% -$83M 0.06% 247
2024
Q1
$150M Buy
1,901,908
+127,916
+7% +$9.77M 0.28% 86
2023
Q4
$140M Sell
1,773,992
-23,288
-1% -$1.66M 0.29% 88
2023
Q3
$126M Sell
1,797,280
-609,857
-25% -$43.2M 0.29% 81
2023
Q2
$166M Buy
2,407,137
+432,633
+22% +$30.8M 0.37% 59
2023
Q1
$147M Buy
1,974,504
+166,931
+9% +$14M 0.37% 60
2022
Q4
$168M Buy
1,807,573
+97,258
+6% +$9.38M 0.44% 48
2022
Q3
$165M Buy
1,710,315
+155,145
+10% +$15.4M 0.49% 43
2022
Q2
$144M Sell
1,555,170
-328,590
-17% -$32.1M 0.42% 49
2022
Q1
$195M Buy
1,883,760
+59,173
+3% +$6.22M 0.48% 41
2021
Q4
$190M Buy
1,824,587
+177,054
+11% +$16.4M 0.46% 49
2021
Q3
$144M Sell
1,647,533
-17,008
-1% -$1.42M 0.4% 56
2021
Q2
$138M Sell
1,664,541
-141,252
-8% -$11.6M 0.4% 57
2021
Q1
$137M Buy
1,805,793
+236,948
+15% +$17.3M 0.46% 49
2020
Q4
$107M Sell
1,568,845
-454,237
-22% -$29.5M 0.4% 58
2020
Q3
$115M Buy
2,023,082
+237,236
+13% +$14.8M 0.51% 45
2020
Q2
$115M Buy
1,785,846
+50,945
+3% +$3.21M 0.72% 29
2020
Q1
$104M Buy
1,734,901
+188,854
+12% +$12.6M 0.8% 27
2019
Q4
$115M Buy
1,546,047
+209,283
+16% +$14.7M 0.7% 29
2019
Q3
$83.4M Buy
1,336,764
+733,455
+122% +$43.5M 0.52% 45
2019
Q2
$33.2M Sell
603,309
-50,350
-8% -$2.71M 0.17% 153
2019
Q1
$49.2M Sell
653,659
-52,296
-7% -$3.23M 0.29% 84
2018
Q4
$46.4M Buy
705,955
+52,296
+8% +$3.9M 0.31% 78
2018
Q3
$49.2M Buy
653,659
+20,715
+3% +$1.48M 0.29% 84
2018
Q2
$41.7M Buy
632,944
+79,858
+14% +$5.26M 0.27% 90
2018
Q1
$34.8M Buy
553,086
+93,560
+20% +$6.71M 0.24% 106
2017
Q4
$36.8M Sell
459,526
-5,800
-1% -$422K 0.29% 88
2017
Q3
$37.3M Buy
465,326
+78,702
+20% +$6.23M 0.29% 88
2017
Q2
$31.3M Sell
386,624
-7,005
-2% -$553K 0.25% 96
2017
Q1
$31.1M Buy
393,629
+16,525
+4% +$1.32M 0.28% 84
2016
Q4
$29.8M Sell
377,104
-37,225
-9% -$3.01M 0.32% 76
2016
Q3
$37M Buy
414,329
+2,981
+0.7% +$281K 0.41% 62
2016
Q2
$38.9M Buy
411,348
+71,815
+21% +$7.16M 0.44% 54
2016
Q1
$35.3M Sell
339,533
-24,998
-7% -$2.43M 0.42% 59
2015
Q4
$36.2M Sell
364,531
-82,653
-18% -$8.09M 0.42% 56
2015
Q3
$43.1M Buy
447,184
+39,983
+10% +$4.2M 0.53% 45
2015
Q2
$42.9M Buy
407,201
+94,750
+30% +$9.68M 0.51% 40
2015
Q1
$32.4M Sell
312,451
-9,827
-3% -$994K 0.4% 55
2014
Q4
$31.3M Buy
322,278
+10,613
+3% +$935K 0.39% 58
2014
Q3
$24.9M Sell
311,665
-4,617
-1% -$364K 0.34% 64
2014
Q2
$24M Buy
316,282
+32,256
+11% +$2.44M 0.36% 58
2014
Q1
$21.3M Buy
284,026
+22,507
+9% +$1.59M 0.34% 63
2013
Q4
$18.7M Sell
261,519
-26,913
-9% -$1.73M 0.31% 68
2013
Q3
$16.6M Sell
288,432
-21,660
-7% -$1.29M 0.29% 69
2013
Q2
$17.8M Buy
+310,092
New +$18M 0.35% 64

Other funds holding CVS

DekaBank Deutsche Girozentrale's CVS Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its CVS Health (CVS) position steady in Q2 2026 at 1,858,556 shares worth $130M. The position accounts for 0.22% of the portfolio, ranked #106.

DekaBank Deutsche Girozentrale first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $195M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 1,858,556 shares of CVS Health worth $130M as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.22% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #106 holding.
  • DekaBank Deutsche Girozentrale first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • DekaBank Deutsche Girozentrale's CVS Health position peaked at $195M in Q1 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.